B

Binex Co Ltd
KOSDAQ:053030

Watchlist Manager
Binex Co Ltd
KOSDAQ:053030
Watchlist
Price: 17 870 KRW 1.53%
Market Cap: 569.1B KRW
Have any thoughts about
Binex Co Ltd?
Write Note

Binex Co Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Binex Co Ltd
Accumulated Depreciation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
B
Binex Co Ltd
KOSDAQ:053030
Accumulated Depreciation
-â‚©62B
CAGR 3-Years
-17%
CAGR 5-Years
-14%
CAGR 10-Years
-17%
Yuhan Corp
KRX:000100
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Accumulated Depreciation
-â‚©54.6B
CAGR 3-Years
-22%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Accumulated Depreciation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Accumulated Depreciation
-â‚©71.8B
CAGR 3-Years
-12%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
C
Celltrion Pharm Inc
KOSDAQ:068760
Accumulated Depreciation
-â‚©133.8B
CAGR 3-Years
-18%
CAGR 5-Years
-19%
CAGR 10-Years
-36%
No Stocks Found

Binex Co Ltd
Glance View

Market Cap
552.6B KRW
Industry
Pharmaceuticals

BINEX Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Busan, Busan. The company went IPO on 2001-08-07. The Company’s products include digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as ointment, creams and others. The company also manufactures bio medicines and raw materials. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
11 364.6 KRW
Overvaluation 36%
Intrinsic Value
Price
B

See Also

What is Binex Co Ltd's Accumulated Depreciation?
Accumulated Depreciation
-62B KRW

Based on the financial report for Sep 30, 2024, Binex Co Ltd's Accumulated Depreciation amounts to -62B KRW.

What is Binex Co Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-17%

Over the last year, the Accumulated Depreciation growth was -15%. The average annual Accumulated Depreciation growth rates for Binex Co Ltd have been -17% over the past three years , -14% over the past five years , and -17% over the past ten years .

Back to Top